Stryker Corp (SYK.N)
BRIEF-Stryker Expects 2017 Adj Net Earnings Per Diluted Share To Be Toward High End Of Previous Range Of $6.45-$6.50
* STRYKER - EXPECT 2017 ADJUSTED NET EARNINGS PER DILUTED SHARE TO BE TOWARD HIGH END OF PREVIOUSLY ANNOUNCED RANGE OF $6.45 TO $6.50
* STRYKER ANNOUNCES MR. HOWARD COX JR WILL RETIRE FROM BOARD OF DIRECTORS
Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.
Dec 7 Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.
Dec 7 Medical device maker Stryker Corp said on Thursday it would buy medical technology company Entellus Medical Inc in a deal valued at about $662 million, adding heft to its ENT business.
* ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH
* STRYKER INCREASES DIVIDEND 11%, DECLARING A $0.47 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:
BRIEF-Stryker receives U.S. FDA HDE approval for the Neuroform Atlas stent system to treat wide neck aneurysms
* Stryker receives U.S. FDA HDE approval for the Neuroform Atlas™ stent system to treat wide neck aneurysms
* Q3 earnings per share view $1.50 -- Thomson Reuters I/B/E/S
* Stryker Corp - Stryker paid EUR 20.00 per share and EUR 3.91 per BSAAR warrant for deal
|Olympus Corp (7733.T)||¥4,255||+5.00|
|Johnson & Johnson (JNJ.N)||$147.02||+1.26|
|Zimmer Biomet Holdings Inc (ZBH.N)||$121.61||-0.49|
|Smith & Nephew plc (SN.L)||1,254.50||-3.50|
|Hill-Rom Holdings, Inc. (HRC.N)||$86.76||-0.03|
|CONMED Corporation (CNMD.OQ)||$55.64||-0.84|
|NuVasive, Inc. (NUVA.OQ)||$51.56||-1.77|
|Globus Medical Inc (GMED.N)||$43.14||-0.52|
|Medtronic PLC (MDT.N)||$85.08||-0.37|
|Terumo Corp (4543.T)||¥5,580||+70.00|